Lekfarm Tri-zidin M Modified-Release Tablets 35mg 60-Pack

Overview

Lekfarm Tri-zidin M is a modified-release tablet formulation containing 35mg of trimetazidine per dose, supplied in a 60-tablet pack. This pharmaceutical product is manufactured by Lekfarm LLC in Belarus and is designed for integration into structured cardiovascular care routines. The modified-release mechanism helps maintain consistent active ingredient levels throughout the day, supporting steady daily management.

Each tablet is precisely dosed to align with standard clinical formulations of trimetazidine. The packaging is engineered to preserve tablet integrity and moisture resistance, ensuring reliable quality until use. This product serves as a practical option for individuals and healthcare providers seeking a standardized trimetazidine supply.

Why You'll Like It

• Modified-release technology supports steady daily ingredient availability
• Standardized 35mg dosage per tablet for consistent routine use
• 60-tablet pack size reduces frequent repurchasing needs
• Manufactured by Lekfarm LLC, a recognized Belarusian pharmaceutical producer
• Designed for straightforward integration into daily cardiovascular care schedules

Who It's For

• Buyers seeking standardized trimetazidine formulations for daily routines
• Individuals preferring modified-release options for consistent management
• Healthcare-conscious consumers looking for reliable cardiovascular support products
• Pharmacy shoppers requiring a 60-tablet supply for extended use

Package Details

Each box contains 60 modified-release tablets (10 tablets per strip, 6 strips). The packaging is designed to protect tablet integrity and maintain moisture resistance. Manufactured by Lekfarm LLC, Belarus.

Common Questions